Waisse Waissi

Faculté De Médecine Lyon Est, 
Lyon, FR 
Faculté De Médecine Lyon Est, 
Lyon, FR 

Overview

Waisse Waissi practices practicing medicine in Lyon, France.

Their clinical expertise encompasses Adult Soft Tissue Sarcoma, Delayed Growth, Pancreatic Cancer, and Oral Cancer.

They are actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 2 clinical trials.

Locations

Faculté De Médecine Lyon Est, Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Study of Complications Related to Treatments in Adults Aged 18 to 65 Years Old Responding to a First Treatment in Oncology or Onco-hematology and Participating in the PASCA (PArcours de Santé au Cours du CAncer) Post-treatment Program.
Study of Complications Related to Treatments in Adults Aged 18 to 65 Years Old Responding to a First Treatment in Oncology or Onco-hematology and Participating in the PASCA (PArcours de Santé au Cours du CAncer) Post-treatment Program.
Enrollment Status: Active_not_recruiting
Publish Date: September 05, 2025
Intervention Type: Other
Study Phase: Not Applicable
Randomized Controlled Trial Evaluating the Efficacy of an Adapted Physical Activity Program Using a Connected Device With Activity Trackers and a Therapeutic Education Program Among Women With Localized Breast Cancer
Randomized Controlled Trial Evaluating the Efficacy of an Adapted Physical Activity Program Using a Connected Device With Activity Trackers and a Therapeutic Education Program Among Women With Localized Breast Cancer
Enrollment Status: Completed
Publish Date: March 22, 2023
Intervention Type: Device, Behavioral
Study Phase: Not Applicable
View 1 Less Clinical Trial

26 Total Publications

Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 17, 2026

Frequently Asked Questions about Waisse Waissi

Is Waisse Waissi a top-rated expert for Adult Soft Tissue Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Waisse Waissi is classified as an Experienced expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Waisse Waissi participate in research or clinical trials?

Yes. Waisse Waissi has published 26 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Waisse Waissi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Waissi's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile